Canary Staked INJ ETF INJC
Strategy
The investment seeks to provide exposure to the price of Injective (“INJ”) held by the Trust, less the expenses of the Trust’s operations and other liabilities; to earn additional INJ through its participation in the staking program administered by the Sponsor, in which staking rewards will be earned through the validation of transactions on the Injective network’s proof-of-stake blockchain is secondary consideration. In seeking to achieve its investment objectives, the Trust will hold INJ and establish its net asset value (“NAV”) by reference to the CoinDesk Injective Benchmark Extended 60m NY Rate (“Pricing Benchmark”).
Ticker | Name | Share Class Type | Investment Status | Morningstar Rating for Funds Overall | Medalist Rating Overall | Inception Date | Total Net Assets for Share Class | Adjusted Expense Ratio | Fee Level Distribution | Minimum Initial Investment | 1-Year Net Flow |
|---|---|---|---|---|---|---|---|---|---|---|---|
INJC | Canary Staked INJ ETF | ETF | Open | — | — | $13.62M | 1.100% | — | — | — |